Literature DB >> 29858640

Comparison of three cut-offs to diagnose clinically significant portal hypertension by liver stiffness in chronic viral liver diseases: a meta-analysis.

Jinzhen Song1, Zida Ma2, Jianbo Huang3, Shiyu Liu4, Yan Luo5, Qiang Lu6, Philipp Schwabl7, Romanas Zykus8, Ashish Kumar9, Matthew Kitson10.   

Abstract

BACKGROUND: Transient elastography-based liver stiffness value (TE-LSV) has been investigated for assessing clinically significant portal hypertension (CSPH). The aetiology of CSPH is an important factor determining TE-LSV. There is insufficient evidence for selecting cut-off values. AIMS: This study performed a meta-analysis to compare the three most widely used cut-off values (around 13.6 kPa, 18 kPa and 22kPa) of TE-LSV for the diagnosis of CSPH in patients with chronic viral liver disease.
METHODS: The PubMed, Ovid, Web of Science and Cochrane Library databases were searched. Diagnostic data for cut-off values around 13.6 kPa, 18 kPa and 22 kPa in each included study were extracted. The bivariate model was performed to estimate pooled sensitivity, specificity, positive likelihood ratio (LR+) and negative likelihood ratio (LR-).
RESULTS: Eleven studies assessing 910 patients were included in this meta-analysis. Pooled sensitivities of cut-off values around 13.6 kPa, 18 kPa and 22 kPa were 0.96 (95% CI 0.93-0.97), 0.85 (0.81-0.89) and 0.74 (0.66-0.80), respectively; pooled specificities were 0.60 (0.47-0.75), 0.80 (0.71-0.87) and 0.94 (0.86-0.97), respectively. Pooled LR+ values were 2.4 (1.6-3.7), 4.4 (2.9-6.8) and 11.5 (5.5-23.5) for cut-off values around 13.6 kPa, 18 kPa and 22 kPa, respectively, for pooled LR- values of 0.07 (0.04-0.13), 0.17 (0.12-0.25) and 0.28 (0.22-0.36), respectively.
CONCLUSION: Cut-off values around 13.6 kPa (high sensitivity) and 22 kPa (high specificity) could be used as screening and confirmation tools, respectively, in the diagnosis of CSPH. Overall, the cut-off value around 22 kPa showed the best performance. KEY POINTS: Transient elastography-based liver stiffness could be used to diagnose portal hypertension. Comparison of certain cut-off values would provide more information for clinical decision-making. Cut-off around 13.6 kPa was able to exclude clinically significant portal hypertension (CSPH) effectively. Cut-off around 22 kPa was able to confirm CSPH effectively.

Entities:  

Keywords:  Diagnosis; Elasticity imaging techniques; Hepatitis; Hypertension, portal; Liver

Mesh:

Year:  2018        PMID: 29858640     DOI: 10.1007/s00330-018-5478-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  34 in total

1.  Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis.

Authors:  Francesco Vizzutti; Umberto Arena; Roberto G Romanelli; Luigi Rega; Marco Foschi; Stefano Colagrande; Antonio Petrarca; Stefania Moscarella; Giacomo Belli; Anna Linda Zignego; Fabio Marra; Giacomo Laffi; Massimo Pinzani
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

2.  New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension.

Authors:  Philipp Schwabl; Simona Bota; Petra Salzl; Mattias Mandorfer; Berit A Payer; Arnulf Ferlitsch; Judith Stift; Friedrich Wrba; Michael Trauner; Markus Peck-Radosavljevic; Thomas Reiberger
Journal:  Liver Int       Date:  2014-07-09       Impact factor: 5.828

3.  Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension.

Authors:  Bogdan Procopet; Annalisa Berzigotti; Juan G Abraldes; Fanny Turon; Virginia Hernandez-Gea; Juan Carlos García-Pagán; Jaime Bosch
Journal:  J Hepatol       Date:  2014-12-13       Impact factor: 25.083

4.  Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications.

Authors:  Matthew T Kitson; Stuart K Roberts; John C Colman; Eldho Paul; Peter Button; William Kemp
Journal:  Scand J Gastroenterol       Date:  2015-01-26       Impact factor: 2.423

5.  Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience.

Authors:  Thomas Reiberger; Arnulf Ferlitsch; Berit Anna Payer; Matthias Pinter; Philipp Schwabl; Judith Stift; Michael Trauner; Markus Peck-Radosavljevic
Journal:  Wien Klin Wochenschr       Date:  2012-06-15       Impact factor: 1.704

Review 6.  A Meta-analysis for the Diagnostic Performance of Transient Elastography for Clinically Significant Portal Hypertension.

Authors:  Myung-Won You; Kyung Won Kim; Junhee Pyo; Jimi Huh; Hyoung Jung Kim; So Jung Lee; Seong Ho Park
Journal:  Ultrasound Med Biol       Date:  2016-10-15       Impact factor: 2.998

7.  Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.

Authors:  M Lemoine; S Katsahian; M Ziol; P Nahon; N Ganne-Carrie; F Kazemi; V Grando-Lemaire; J-C Trinchet; M Beaugrand
Journal:  Aliment Pharmacol Ther       Date:  2008-11-01       Impact factor: 8.171

8.  Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease.

Authors:  C Bureau; S Metivier; J M Peron; J Selves; M A Robic; P A Gourraud; O Rouquet; E Dupuis; L Alric; J P Vinel
Journal:  Aliment Pharmacol Ther       Date:  2008-04-04       Impact factor: 8.171

Review 9.  Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B.

Authors:  Y Li; Y-S Huang; Z-Z Wang; Z-R Yang; F Sun; S-Y Zhan; X-E Liu; H Zhuang
Journal:  Aliment Pharmacol Ther       Date:  2015-12-15       Impact factor: 8.171

10.  QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.

Authors:  Penny F Whiting; Anne W S Rutjes; Marie E Westwood; Susan Mallett; Jonathan J Deeks; Johannes B Reitsma; Mariska M G Leeflang; Jonathan A C Sterne; Patrick M M Bossuyt
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

View more
  7 in total

Review 1.  Diagnostic accuracy of transient elastography in diagnosing clinically significant portal hypertension in patients with chronic liver disease: a systematic review and meta-analysis.

Authors:  Ashish Kumar; Hitoshi Maruyama; Anil Arora; Praveen Sharma; Shrihari Anil Anikhindi; Naresh Bansal; Mandhir Kumar; Piyush Ranjan; Munish Sachdeva; Shivam Khare
Journal:  J Med Ultrason (2001)       Date:  2022-07-25       Impact factor: 1.878

2.  Limited diagnostic value of liver stiffness for clinically significant portal hypertension in HBV-related cirrhosis.

Authors:  Mengmeng Zhang; Xiaoxia Niu; Di Zhao; Ruping Qi; Xuexin Qi; Jinghui Dong; Yuan Liu; Xu Bai; Qiang Yu; Changchun Liu; Jianming Cai
Journal:  Abdom Radiol (NY)       Date:  2022-08-09

3.  Spleen Transient Elastography and Damping Index Identify a Subgroup of Patients Without an Acute or Chronic Response to Beta-Blockers.

Authors:  Elba Llop; Christie Perelló; Teresa Fontanilla; Juan de la Revilla; Marta Hernández Conde; Marta López; Javier Minaya; Carlos Ferre; Javier Abad; Carlos Fernández Carrillo; José Luís Martínez; Natalia Fernández Puga; María Trapero; Ismael El Hajra; Elena Santos; José Luis Calleja
Journal:  Front Med (Lausanne)       Date:  2022-06-22

4.  Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL).

Authors:  Akash Shukla; Ananta Shreshtha; Amar Mukund; Chhagan Bihari; C E Eapen; Guohong Han; Hemant Deshmukh; Ian Homer Y Cua; Cosmas Rinaldi Adithya Lesmana; Mamun Al Meshtab; Masayoshi Kage; Roongruedee Chaiteeraki; Sombat Treeprasertsuk; Suprabhat Giri; Sundeep Punamiya; Valerie Paradis; Xingshun Qi; Yasuhiko Sugawara; Zaigham Abbas; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-07-08       Impact factor: 6.047

5.  Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma.

Authors:  Alexandra Souhami; Riccardo Sartoris; Pierre-Emmanuel Rautou; François Cauchy; Mohamed Bouattour; François Durand; Valerio Giannelli; Elia Gigante; Laurent Castera; Dominique Valla; Olivier Soubrane; Valérie Vilgrain; Maxime Ronot
Journal:  JHEP Rep       Date:  2020-07-17

6.  Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome.

Authors:  Elton Dajti; Federico Ravaioli; Antonio Colecchia; Giovanni Marasco; Amanda Vestito; Davide Festi
Journal:  Can J Gastroenterol Hepatol       Date:  2019-01-02

7.  Can Location of Stiffness Measurement Impact Spleen 2-Dimensional Shear Wave Elastography Measurement?

Authors:  Jinzhen Song; Jiawu Li; Yan Luo; Qiang Lu
Journal:  Ultrasound Q       Date:  2022-06-01       Impact factor: 1.462

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.